Surg-25. stability of shunt programmable valve settings with simultaneous use of the optune transducer array

In this study, shunt valve settings were stable over a period of five days despite concurrent Optune therapy. This is reassuring for patients with GBM that require simultaneous treatment with both the Optune device and a programmable shunt system.

Source: Neuro-Oncology - November 6, 2016 Category: Cancer & Oncology Authors: Chan, A., Birk, H. Tags: SURGICAL THERAPY Source Type: research